Hypertensive crisis and myocardial infarction following massive clonidine overdose

Annals of Pharmacotherapy

Volumn 34, Issue 5, 2000, Pages 611-615

  Frye, Carla B ^a   Vance, Michael A ^b  

^a BUTLER UNIVERSITY   (United States)

^b NONE

Author keywords

Clonidine; Epidural analgesia; Medication error; Myocardial infarction; Naloxone; Overdose

Indexed keywords

CLONIDINE; HYDROMORPHONE; NALOXONE;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER PAIN; CASE REPORT; CLINICAL FEATURE; DRUG OVERDOSE; DRUG POTENTIATION; DRUG SAFETY; EPIDURAL ANESTHESIA; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; PRIORITY JOURNAL;

EID: 0034014792     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.19257     Document Type: Article

References (22)

1. Kobinger W. Central α-adrenergic systems as targets for hypotensive drugs. Rev Physiol Biochem Pharmacol 1978;81:40-101.
2. Bousquet P, Feldman J, Schwartz J. Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines. J Pharmacol Exp Ther 1984;230:232-6.
3. 2A-receptor transgenic mice. Br J Pharmacol 1999;126:1522-30.
4. Chrisp P, Faulds D. Moxonidine: a review of its pharmacology and therapeutic use in essential hypertension. Drugs 1992;44:993-1012.
5. Yaksh TL. Pharmacology of spinal adrenergic systems which modulate spinal nocioceptive processing. Pharmacol Biochem Behav 1985;22: 845-58.
6. Nakamura M, Ferriera SH. Peripheral analgesic action of clonidine: mediation by release of endogenous enkephalin-like substance. Eur J Pharmacol 1988;146:223-8.
7. 2-adrenoreceptor agonist: defining the role in clinical anesthesia. Anesthesiology 1991;74:581-605.
8. 2-Adrenergic agonists for regional anesthesia. Anesthesiology 1996;85:655-74.
9. Segal R, Murali S, Tipton K. Treatment of chronic unstable angina pectoris: use of a totally implantable programmable device for continuous intrathecal infusion of opiates: case report. Neurosurgery 1996;38:385-8.
10. Salva KM, Kuhn JG. Overdose of morphine sulfate injection during refilling of an implanted infusion pump. Clin Pharm 1987;6:577-80.
11. Litovitz TL, Bailey KM, Schmitz BF, Holm KC, Klein-Schwartz W. 1990 annual report of the American Association of Poison Control Centers National Data Collection System. Am J Emerg Med 1991;9:461-501.
12. Olsson JM, Pruitt AW. Management of clonidine ingestion in children. J Pediatr 1983;103:646-50.
13. Conner CS, Watanabe AS. Clonidine overdose: a review. Am J Hosp Pharm 1979;36:906-11.
14. Niemann JT, Getzug T, Murphy W. Reversal of clonidine toxicity by naloxone. Ann Emerg Med 1986;15:1229-31.
15. Gremse DA, Artman M, Boerth RC. Hypertension associated with naloxone treatment for clonidine poisoning. J Pediatr 1986;108:776-8.
16. Manelli M, Maggi M, De Feo ML, Cuomo S, Forti G, Moroni F, et al. Naloxone administration releases catecholamines. N Engl J Med 1983; 308:654-5.
17. Brimacomber J, Archdeacon J, Newell S, Martin J. Two cases of naloxone-induced pulmonary oedema - the possible use of phentolamine in management. Anaesth Inten Care 1991;19:578-80.
18. Mariani PJ. Seizure associated with low-dose naloxone. Am J Emerg Med 1989;7:127-9.
19. Domino LE, Domino SE, Stocksill MS. Relationship between plasma concentration of clonidine and mean arterial pressure during an accidental clonidine overdose. Br J Clin Pharmacol 1986;21:71-4.
20. Frisk-Holmberg M, Paalzow L, Wibell L. Relationship between the cardiovascular effects and steady-state kinetics of clonidine in hypertension. Eur J Clin Pharmacol 1984;26:309-13.
21. Ling W, Wesson DR. Drugs of abuse - opiates. West J Med 1990;152: 565-72.
22. Naranjo CA, Busto U, Sellers EM, Sando P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.